Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.73 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.45 |
| ▸ | ENPEP | Q07075 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 2/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL888042 | 1.00 | PTGS1 (0.73) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Cysteine SCHEMBL3396295 | 0.93 | PTGS1 (0.70) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Cysteine SCHEMBL3396289 | 0.93 | PTGS1 (0.70) | PTGS1SLC7A11LMNASLC1A1ENPEP | |
| Serine SCHEMBL26613653 | 0.86 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPALDH1A1 | |
| Serine SCHEMBL27748272 | 0.86 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPALDH1A1 | |
| Serine SCHEMBL1162414 | 0.86 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPALDH1A1 | |
| Serine SCHEMBL17113864 | 0.86 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPALDH1A1 | |
| Serine SCHEMBL1162408 | 0.86 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPALDH1A1 | |
| Serine SCHEMBL17113867 | 0.86 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPALDH1A1 | |
| Cysteine SCHEMBL1868335 | 0.85 | PTGS1 (1.00) | PTGS1SLC7A11SLC1A1ENPEPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8986700-B2 | Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2015-03-24 | — | — | US | disclosed |
| EP-1546206-B1 | Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitiopes | QUEENSLAND INST MED RES (AU) | 2014-12-17 | — | — | EP | disclosed |
| US-20110280899-A1 | Novel Immunogenic Lipopeptides Comprising T-Helper And Cytotoxic T-Lymphocyte (CTL) Epitopes | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2011-11-17 | — | — | US | disclosed |
| EP-2314630-A1 | Method of producing immunogenic lipopeptides comprising T-helper and Cytotoxic T Lymphocyte (CTL) epitopes | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2011-04-27 | — | — | EP | disclosed |
| US-7833532-B2 | Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2010-11-16 | — | — | US | disclosed |
| EP-1546206-A4 | NOVEL IMMUNOGENIC LIPOPEPTIDES COMPRISING T-HELPER AND CYTOTOXIC T LYMPHOCYTE (CTL) EPITOPES | QUEENSLAND INST MED RES (AU) | 2007-10-10 | — | — | EP | disclosed |
| US-20070160631-A1 | Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2007-07-12 | — | — | US | disclosed |
| EP-1546206-A1 | NOVEL IMMUNOGENIC LIPOPEPTIDES COMPRISING T-HELPER AND CYTOTOXIC T LYMPHOCYTE (CTL) EPITOPES | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004014957-A1 | NOVEL IMMUNOGENIC LIPOPEPTIDES COMPRISING T-HELPER AND CYTOTOXIC T LYMPHOCYTE (CTL) EPITOPES | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2004-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110280899-A1 | Novel Immunogenic Lipopeptides Comprising T-Helper And Cytotoxic T-Lymphocyte (CTL) Epitopes | LTA, LY96, CD4 | PTGS1 4001/4885SLC7A11 1346/4885LMNA 1433/4885 |
| US-20070160631-A1 | Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes | LY96, LTA, CD4 | PTGS1 4132/4885SLC7A11 1273/4885LMNA 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.